List, James F.

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

Lambers Heerspink, H. J., de Zeeuw, D., Wie, L., Leslie, B., & List, J. (2013) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 837

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

List, J. F., Woo, V., Morales, E., Tang, W., & Fiedorek, F. T. (2009) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 698

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control

Kohan, D. E., Fioretto, P., Tang, W., & List, J. F. (2014) · Kidney International

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 652

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans

List, J. F., & Whaley, J. M. (2011) · Kidney International

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 184

Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes

Sjöström, C. D., Johansson, P., Ptaszynska, A., List, J., & Johnsson, E. (2015) · Diabetes and Vascular Disease Research

Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 97